Quantinno Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.2M Buy
639,603
+236,256
+59% +$19.5M 0.09% 267
2025
Q4
$34.4M Buy
403,347
+61,928
+18% +$5.08M 0.07% 323
2025
Q3
$26.6M Buy
341,419
+81,231
+31% +$6.35M 0.07% 318
2025
Q2
$20.3M Buy
260,188
+66,910
+35% +$4.99M 0.09% 252
2025
Q1
$14M Buy
193,278
+32,042
+20% +$2.29M 0.09% 253
2024
Q4
$11.9M Buy
161,236
+108,053
+203% +$7.56M 0.12% 162
2024
Q3
$3.51M Buy
53,183
+12,028
+29% +$874K 0.05% 519
2024
Q2
$3.8M Sell
41,155
-4,223
-9% -$374K 0.07% 339
2024
Q1
$4.34M Buy
45,378
+35,161
+344% +$2.95M 0.09% 231
2023
Q4
$779K Sell
10,217
-10,250
-50% -$713K 0.03% 698
2023
Q3
$1.42M Sell
20,467
-12,794
-38% -$1.03M 0.06% 413
2023
Q2
$3.14M Buy
33,261
+12,529
+60% +$1.09M 0.18% 103
2023
Q1
$1.72M Buy
20,732
+2,792
+16% +$219K 0.11% 232
2022
Q4
$1.34M Buy
17,940
+14,925
+495% +$1.15M 0.1% 293
2022
Q3
$249K Buy
3,015
+218
+8% +$21K 0.03% 532
2022
Q2
$266K Buy
+2,797
New +$290K 0.04% 487
2020
Q2
Sell
-9,876
Closed -$621K 352
2020
Q1
$621K Buy
+9,876
New +$712K 0.39% 70

Other funds holding EW

Quantinno Capital Management's EW Position: Q1 2026 in Review

Quantinno Capital Management increased its Edwards Lifesciences (EW) stake by 59% in Q1 2026, buying an estimated $19.5M and bringing the position to 639,603 shares worth $51.2M. The position accounts for 0.09% of the portfolio, ranked #267.

Quantinno Capital Management first reported a position in EW in Q1 2020 and has held it in 17 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Quantinno Capital Management held 639,603 shares of Edwards Lifesciences worth $51.2M as of Q1 2026.
  • Quantinno Capital Management bought 236,256 Edwards Lifesciences shares in Q1 2026, an estimated $19.5M.
  • Edwards Lifesciences made up 0.09% of Quantinno Capital Management's portfolio in Q1 2026, its #267 holding.
  • Quantinno Capital Management first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 17 quarters since.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.